↓ Skip to main content

The Role of Progesterone Receptors in Breast Cancer

Overview of attention for article published in Drug Design, Development and Therapy, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
336 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of Progesterone Receptors in Breast Cancer
Published in
Drug Design, Development and Therapy, January 2022
DOI 10.2147/dddt.s336643
Pubmed ID
Authors

Zhuo Li, Hongrui Wei, Siyan Li, Pei Wu, Xiaoyun Mao

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 336 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 335 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 8%
Student > Master 24 7%
Researcher 19 6%
Unspecified 18 5%
Student > Ph. D. Student 15 4%
Other 28 8%
Unknown 206 61%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 10%
Medicine and Dentistry 33 10%
Unspecified 18 5%
Agricultural and Biological Sciences 14 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 2%
Other 22 7%
Unknown 209 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#3,241,763
of 25,998,826 outputs
Outputs from Drug Design, Development and Therapy
#175
of 2,299 outputs
Outputs of similar age
#75,152
of 519,499 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 31 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,299 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,499 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.